Kazia Therapeutics Share Price Australian S.E.
Equities
KZA
AU000000KZA9
Biotechnology & Medical Research
Sales 2022 | 10T 6.6T 6L | Sales 2023 | 555 366.28 30.59T | Capitalization | 3.97Cr 2.62Cr 218.91Cr |
---|---|---|---|---|---|
Net income 2022 | -2.4Cr -1.58Cr -132.28Cr | Net income 2023 | -2Cr -1.32Cr -110.23Cr | EV / Sales 2022 | 7,714 x |
Net cash position 2022 | 73.61L 48.58L 41Cr | Net cash position 2023 | 34.45L 22.73L 19Cr | EV / Sales 2023 | 65,355 x |
P/E ratio 2022 |
-3.27
x | P/E ratio 2023 |
-1.55
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 45.6% |
Latest transcript on Kazia Therapeutics
1st Jan change | Capi. | |
---|---|---|
+26.37% | 4.82TCr | |
-1.01% | 4.17TCr | |
+46.00% | 4.1TCr | |
-5.31% | 2.88TCr | |
+9.34% | 2.56TCr | |
-21.69% | 1.9TCr | |
+6.23% | 1.29TCr | |
+26.99% | 1.2TCr | |
-3.38% | 1.18TCr |